Potential clinical application of the cancer antigen CA‑62 for differential diagnosis of prostate cancer and benign prostatic hyperplasia at the elevated prostate‑specific antigen

Purpose of the study. Evaluation of the diagnostic characteristics of the CA‑62 marker for epithelial carcinomas for detecting early‑stage prostate cancer in a double‑blind clinical study. This study is also focused on the possibility of using the CA‑62 antigen as an auxiliary tool for decision‑maki...

全面介绍

书目详细资料

发表在:	Исследования и практика в медицине
Main Authors:	Zh. R. Cherkasova, S. A. Tsurkan, A. I. Prostyakova, A. M. Boroda, A. A. Rozhkov, Yu. N. Pirogova, N. M. Nikitina, M. I. Sekacheva
格式:	文件
语言:	俄语
出版:	QUASAR, LLC 2023-03-01
主题:	cancer marker prostate cancer benign prostatic hyperplasia prostate‑specific antigen ca‑62 cancer antigen prostate biopsy
在线阅读:	https://www.rpmj.ru/rpmj/article/view/874